Literature DB >> 2549301

Endocytic pathway of high density lipoprotein via trans-Golgi system in rat resident peritoneal macrophages.

K Takahashi1, S Fukuda, M Naito, S Horiuchi, K Takata, Y Morino.   

Abstract

Interaction of high density lipoprotein (HDL) with rat resident peritoneal macrophages was investigated by morphological and biochemical approaches. Binding studies at 0 degree C demonstrated saturable binding sites for 125I-HDL on the surface membrane. When cells were incubated with 125I-HDL at 37 degrees C, the cell-associated radioactivity increased with time, but intracellular degradation of HDL did not occur. Rather, the cell-associated 125I-HDL was released intact into the medium. Two morphological probes were employed to visualize the post-binding fate of HDL. Horseradish peroxidase and ferritin conjugates of HDL showed specific bindings to the coated pits of the plasma membranes and were internalized and delivered through receptosomes to a trans-Golgi system. They were then resecreted as secretory vesicles from the cells. Parallel experiments with transferrin-horseradish peroxidase conjugates revealed an endocytic pathway identical or very similar to that observed with HDL. These results provide evidence that internalization and subsequent nonlysosomal pathway via the trans-Golgi system are involved in receptor-mediated endocytosis of HDL by macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549301

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification.

Authors:  Y Nagano; H Arai; T Kita
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

2.  HDL3-mediated cholesterol efflux from cultured enterocytes: the role of apoproteins A-I and A-II.

Authors:  G Herold; U Hesse; F Wisst; C Fahr; M Fahr; G Rogler; I Geerling; E F Stange
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

3.  Cellular uptake and catabolism of high-density-lipoprotein triacylglycerols in human cultured fibroblasts: degradation block in neutral lipid storage disease.

Authors:  N Hilaire; A Nègre-Salvayre; R Salvayre
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

4.  Lipid utilization by human lymphocytes is correlated with high-density-lipoprotein binding site activity.

Authors:  Q Xu; G Jürgens; L A Huber; G Böck; H Wolf; G Wick
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.

Authors:  N H Choi-Miura; T Sakamoto; S Ohtaki; H Nakamura; S Ishizawa; Y Takagi; K Gomi; M Tomita
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain.

Authors:  K Bos; C Wraight; K K Stanley
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

7.  Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann-Pick diseases.

Authors:  Mark L Schultz; Maria V Fawaz; Ruth D Azaria; Todd C Hollon; Elaine A Liu; Thaddeus J Kunkel; Troy A Halseth; Kelsey L Krus; Ran Ming; Emily E Morin; Hayley S McLoughlin; David D Bushart; Henry L Paulson; Vikram G Shakkottai; Daniel A Orringer; Anna S Schwendeman; Andrew P Lieberman
Journal:  BMC Med       Date:  2019-11-11       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.